Dr Jean-Yves Parisot Will Become CEO Of Symrise
Feb 29 (Reuters) -SYMRISE AG SY1G.DE:
SYMRISE AG - SYMRISE AG: CEO CHANGE AT SYMRISE AG: DR HEINZ-JÜRGEN BERTRAM HANDS OVER TO DR JEAN-YVES PARISOT
SYMRISE AG - DR JEAN-YVES PARISOT WILL BECOME CEO OF SYMRISE AG, EFFECTIVE END OF 31 MARCH 2024
SYMRISE AG - SUPERVISORY BOARD HAS ALSO RENEWED CONTRACT OF DR JEAN-YVES PARISOT FOR ANOTHER FOUR YEARS UNTIL END OF SEPTEMBER 2028
SYMRISE AG - THIS HAS BEEN DECIDED BY COMPANY'S SUPERVISORY BOARD IN ITS MEETING TODAY
SYMRISE AG - SUPERVISORY BOARD HAS ALSO RENEWED CONTRACT OF DR JEAN-YVES PARISOT FOR ANOTHER FOUR YEARS UNTIL END OF SEPTEMBER 2028
SYMRISE AG - HE TAKES OVER AS CEO FROM DR HEINZ-JÜRGEN BERTRAM, WHOSE CONTRACT ORIGINALLY WOULD HAVE EXPIRED BY END OF OCTOBER 2025 AND WHO IS NOW RETIRING IN BEST MUTUAL CONSENT AND AGREEMENT
SYMRISE AG - HE WILL CONTINUE TO WORK CLOSELY WITH DR JEAN-YVES PARISOT TO ENSURE A SMOOTH HANDOVER
Source text for Eikon: ID:nEQ8jMfHGa
Further company coverage: SY1G.DE
(Gdansk Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
